1. Home
  2. MYNZ vs GITS Comparison

MYNZ vs GITS Comparison

Compare MYNZ & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • GITS
  • Stock Information
  • Founded
  • MYNZ 2021
  • GITS 2018
  • Country
  • MYNZ Germany
  • GITS South Korea
  • Employees
  • MYNZ N/A
  • GITS N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • GITS
  • Sector
  • MYNZ Health Care
  • GITS
  • Exchange
  • MYNZ Nasdaq
  • GITS Nasdaq
  • Market Cap
  • MYNZ 11.2M
  • GITS 11.6M
  • IPO Year
  • MYNZ 2021
  • GITS N/A
  • Fundamental
  • Price
  • MYNZ $4.83
  • GITS $0.19
  • Analyst Decision
  • MYNZ Hold
  • GITS
  • Analyst Count
  • MYNZ 2
  • GITS 0
  • Target Price
  • MYNZ N/A
  • GITS N/A
  • AVG Volume (30 Days)
  • MYNZ 135.3K
  • GITS 1.3M
  • Earning Date
  • MYNZ 10-21-2024
  • GITS 11-20-2024
  • Dividend Yield
  • MYNZ N/A
  • GITS N/A
  • EPS Growth
  • MYNZ N/A
  • GITS N/A
  • EPS
  • MYNZ N/A
  • GITS N/A
  • Revenue
  • MYNZ $917,203.00
  • GITS N/A
  • Revenue This Year
  • MYNZ $21.95
  • GITS N/A
  • Revenue Next Year
  • MYNZ $30.77
  • GITS N/A
  • P/E Ratio
  • MYNZ N/A
  • GITS N/A
  • Revenue Growth
  • MYNZ 16.23
  • GITS 85.47
  • 52 Week Low
  • MYNZ $0.18
  • GITS $0.17
  • 52 Week High
  • MYNZ $7.95
  • GITS $0.75
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 53.87
  • GITS N/A
  • Support Level
  • MYNZ $3.86
  • GITS N/A
  • Resistance Level
  • MYNZ $6.81
  • GITS N/A
  • Average True Range (ATR)
  • MYNZ 0.74
  • GITS 0.00
  • MACD
  • MYNZ -0.09
  • GITS 0.00
  • Stochastic Oscillator
  • MYNZ 32.88
  • GITS 0.00

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: